Skip to main content
. 2023 Feb 28;14:1081741. doi: 10.3389/fendo.2023.1081741

Table 3.

meta-analysis of SNV-eGFRcreatinine summary data in diabetes mellitus and its subtypes (model 2).

Genetic variant (EA) Population N Effect
(Beta [95% CI])
PHET P-value
rs144360241 (C) T1D 1,916 -0.12 [-0.32; 0.08] 0.26 0.25
T2D 15,745 0.01 [-0.02; 0.04] 0.37 0.66
Combined DM 17,661 0.00 [-0.02; 0.03] 0.32 0.78
rs45551835 (A) T1D 2,712 -0.05 [-0.16; 0.07] 0.25 0.43
T2D 15,724 0.01 [0.00; 0.03] 0.03* 0.14
Combined DM 18,436 0.01 [0.00; 0.03] 0.05 0.18
rs141640975 (A) T1D 1,916 0.10 [-0.17; 0.38] 0.4 0.46
T2D 15,746 0.00 [-0.04; 0.05] 0.58 0.88
Combined DM 17,662 0.01 [-0.04; 0.05] 0.67 0.8
rs1801239 (C) T1D 2,712 0.00 [-0.04; 0.05] 0.53 0.94
T2D 15,741 0.00 [-0.01; 0.01] 0.03* 0.77
Combined DM 18,453 0.00 [-0.01; 0.01] 0.15 0.76

SNV, single nucleotide variant; eGFRcreatinine, log-transformed estimated glomerular filtration rate based on the CKD-EPI2012 equation; EA, effect allele (i.e., minor allele); N, sample size; Beta, Beta coefficient; CI, confidence interval; PHet, P-value for heterogeneity across studies. PHet< 0.05 indicates variation; T1D: Type 1 diabetes; T2D: Type 2 diabetes; Combined DM: T1D and T2D combined.